Pharmaceutical and Life Sciences

We have a good understanding of the issues facing the Pharmaceutical and Life Sciences Sector and have worked with some of the industry’s niche pharmaceutical companies such as ProStrakan and Galderma to develop their managers to inspire and engage their people to improve the business’ performance and drive competitive advantage.

The UK pharmaceutical and life sciences industry is high-tech, research-intensive, innovative and highly diverse, spanning bio-pharmaceuticals, diagnostics, devices and medical technology engineering. UK companies play a key role in sustaining high value-jobs, and are vital to the delivery of modern high quality healthcare to patients across the UK and the world.  The sector generates a turnover of over £50 billion, and employs an estimated 176,000 people in the UK.   The UK has the 4th largest pharmaceutical sector in the world and GlaxoSmithKline and AstraZeneca are the 2nd and 4th largest companies globally based on market share of global sales.

Drivers for change in the sector include:

• As the population ages, there will be an increased demand for healthcare, both in terms of drugs and care (e.g. assisted living).

• Greater awareness amongst the general population of wellbeing issues is also likely to have a significant impact on the demand for health-related goods and services.

• However, pressures to reduce healthcare spending and the growth of generics have caused industry returns to be under pressure which will continue to challenge organisations to achieve even greater efficiencies within their operations.

• Desire of governments and societies to improve healthcare outcomes; and bring in new partners for a more sustainable, personalised and patient-centric approach to health that is focused on value.

We can develop your managers and staff to deal with these challenges and deliver a fundamental shift in the culture and performance of your business. We have the unique ability to deeply understand your business vision, strategy, and goals and to design development interventions that will deliver significant business benefits.  We have worked with organisations such as the Association of the British Pharmaceutical Industry, Chiesi and Brooks  Life Sciences.   To learn more about our work in this sector and the impact we have had read our Galderma case study.  Alternatively see how clients such as The General Pharmaceutical Council have benefited from our support by visiting What Our Clients Say.